Tombot Closes $7 Million Series A3 Growth Financing to Scale Operations and Expand Companion Robotics Product Line

LOS ANGELES--(BUSINESS WIRE)--Tombot, a leader in health and wellness robotic companion animals, today announced the successful closing of a $7 million Series A3 financing round. The round includes investments from Caduceus Capital Partners, Wavemaker 360, the Lutheran Foundation for Long Term Living, and Florida Community Health Network.

This financing positions Tombot to scale manufacturing, expand operational capabilities, and accelerate commercialization efforts ahead of its planned Fall 2026 customer launch. The company has already secured more than 23,000 pre-order and waitlist customers for its flagship product named “Jennie,” providing strong market validation and visibility into initial demand as it prepares for its first customer shipments.

The investment comes as demand continues to grow for innovative technologies that address loneliness, behavioral health, aging-in-place, and caregiver support. Tombot's robotic companion animals are designed to provide comfort, engagement, and emotional connection for older adults and others who can benefit from animal companionship but are unable to care for a live pet.

"This financing represents an important milestone as we transition from product development to commercial scale," said Tombot Founder and CEO Tom Stevens. "We are fortunate to have investors who recognize both the significant market opportunity and the positive social impact of companion robotics. Their support will enable us to meet growing customer demand, execute a successful market launch, and continue building a broader portfolio of products that set the bar for emotional support through technology."

The investor group brings a unique combination of healthcare providers, aging-services, and innovation expertise to Tombot's growth strategy.

"Within minutes of our conversation with Tom and seeing his robotic companion come to life, the potential impact of this technology for older adults and individuals facing cognitive challenges became immediately apparent,” said Dr. Mark Gusek, President and CEO of the Lutheran Foundation. “Given our organization’s longstanding commitment to enhancing the quality of care and well-being of older adults, we were pleased to provide launch funding to Tombot, Inc. to support the development and advancement of its lifelike robotic dog. This innovative product has the potential to transform the daily lives of individuals, families, and communities affected by mental health and cognitive challenges who are unable to safely or practically care for a live pet."

Managing Partner Ryan McKindles of Caduceus Capital Partners offered a similar take: “The convergence of an aging population, caregiver shortages, and increasing loneliness underscores the need for innovative solutions that expand access to care and support mental well-being." McKindles added, “Caduceus was honored to lead Tombot’s Series A last year, and we are pleased to continue supporting the company through this additional investment.”

Since Jennie’s emergence in the marketplace in early 2024, Tombot has generated significant market interest from consumers, healthcare providers, senior living organizations, and caregiving communities. The company enters its commercialization phase built upon an ever-expanding foundation of strategic relationships across healthcare and aging-services sectors, positioning itself to capitalize on the rapidly growing demand for companion technologies that support emotional well-being, healthy aging, and caregiver resilience.

The company’s Series A3 financing further strengthens Tombot's position at the convergence of robotics, healthcare, and consumer technology, creating a foundation for future growth as the company expands its product platform and market reach.

About Tombot:

Tombot is a Santa Clarita, CA-based robotic animal and digital health solutions company. Its first product, “Jennie”—a lifelike robotic Labrador puppy—was created to support the 300+ million seniors worldwide living with dementia or mild cognitive impairment, as well as individuals coping with anxiety, loneliness, autism, and PTSD. Exceptionally realistic and fully autonomous, Jennie mimics the movements and responses of an 8-10 week-old puppy, providing the companionship and health benefits of a live animal. With more than 23,000 pre-order and waitlist customers, Jennie has already gained global recognition for advancing robotic solutions that support emotional wellbeing.

For more information about Jennie, visit:
www.Tombot.com